Next-Generation Cancer Diagnostics: Technologies and Global Markets

Report Code: BIO081D

Publish Date: Jun 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global next-generation cancer diagnostics market reached $8.7 billion in 2022 and should reach $15 billion by 2027, with a compound annual growth rate (CAGR) of 11.5% during the forecast period of 2022-2027.

Report Includes

  • 15 data tables and 80 additional tables
  • An overview of the global market and technologies for next generation cancer diagnostics
  • Estimation of the market size and analyses of global market trends, with data from 2021, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the current and future market potential and quantification of next generation cancer diagnostics market based on type, application, and region
  • Description of arrays and microfluidics (LOAC) technologies, multiplex conventional technologies, next generation sequencing technology and polymerase chain reaction (PCR) technology
  • Analysis of underlying technological, environmental, legal/regulatory, and political trends that may influence the size and nature of the market
  • Coverage of the key initiatives and programs related to the next generation cancer diagnostics market
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
  • Company profiles of major players within the industry, including Abbott Laboratories, Illumina Inc., Becton, Dickinson and Co., and Illumina Inc.

Report Scope

This research report analyzes leading next-generation diagnostic technologies, including next generation sequencing (NGS), polymerase chain reaction (PCR), multiplex conventional, cell or extracellular vesicle capture, and arrays/microfluidics. The report also discusses various liquid biopsy platforms and how these compare with tissue-based testing.

The report discusses several significant, large-scale research initiatives contributing to cancer diagnostic development. Key forces driving the market are discussed.

An in-depth analysis of key companies operating in the next-generation cancer diagnostic and technologies market is also included. The information also focuses on companies involved in developing products and emerging technologies.

The market for next-generation cancer diagnostics is analyzed in depth. The market is analyzed by cancer site (bladder, brain, breast, colorectal, cancer of unknown primary, gastric, gynecologic, hematologic, kidney, liver, lung, pan-cancer, pancreatic, prostate, melanoma, and thyroid), by test purpose (screening/early detection, diagnosis, monitoring, therapy guidance), by test platform (arrays/microfluidics, cell/EV capture, multiplex conventional, PCR and NGS) and by geography (North America, Europe, Asia-Pacific, and Rest of World).

The base year for market data is 2021, with historical data provided for 2020 and 2019 and forecast data provided through 2027. Historical, base year, and forecast data are provided for each market segment of the report.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $7.8 billion
Market size forecast $15 billion
Growth rate CAGR of 11.5% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered Cancer Site, Purpose of Analysis, Test Platform, Region
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Companies studied
ABBOTTABBVIE INC.
ADVANCED CELL DIAGNOSTICS INC.AGILENT TECHNOLOGIES INC.
ARTIVION INC.BD
BENITEC BIOPHARMACALADRIUS BIOSCIENCES
CELGENE CORP.COMMENCE BIO
DEPUY SYNTHES (MEDICAL DEVICE BUSINESS SERVICES INC.)DRAGERWERK AG & CO. KGAA
EPIC SCIENCESGENEXINE INC.
GERONILLUMINA INC.
IMMUNOCELLULAR THERAPEUTICS LTD.INEX INNOVATE PRIVATE LTD.
INIVATA LTD.INTERPACE DIAGNOSTICS LLC.
INVIVOSCRIBE INC.MEDTRONIC
MERCK KGAANOVARTIS AG
ONCOCYTE CORP.ONCOMED PHARMACEUTICALS INC.
PLURISTEM THERAPEUTICS INC.SILICON BIOSYSTEMS S.P.A
SPHERE FLUIDICSTHERMO FISHER SCIENTIFIC INC.
VITATEX INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global market for next generation cancer diagnostics technologies and global market was valued at $7.8 billion in 2021. The market is forecast to grow at a compound annual growth rate (CAGR) of 11.5 % to reach $15 billion in 2027. In this report, the global market is segmented by type and region. By type, the market is segmented into products.
Cancer burdens patients, their families, the healthcare system, and society. The burden includes pain, suffering, and economic effects. Next-generation diagnostics can significantly help to reduce this burden at all stages of the disease, from early detection to diagnosis, therapy management, and monitoring, during and after treatment.
The Cancer site, Technology Platform, Purpose of Analysis and Test Platform products and technology market is segmented on the type and region. The type is further divided into products and Application.
Products segment will dominate the market by the end of 2027.
North America has the highest market share.
  • Abbott
  • Johnson & Johnson
  • Novartis
  • Roche
  • Termo fisher

Analyst Credentials

Kalyani Kottapenta – Assistant Manager, Life Sciences
Kalyani Kottapenta is a research professional with nine years of experience in the life sciences and healthcare industry. Her expertise in qualitative and quantitative market information, including market dynamics like market sizing, advanced excel based market modeling, data analysis, forecasting, company share analysis, and competitive landscape assessment of the medical device industry, developing custom reports. She holds a master’s degree in Microbiology and a bachelor’s in Biotechnology and Chemistry.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Next-Generation Cancer Diagnostics: Technologies and Global Markets166Free
Chapter- 1: Introduction8Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market and Technology Background20Free
Chapter- 4: Cancer Diagnostics Market25Free
Chapter- 5: Market Breakdown Application by Cancer Site40Free
Chapter- 6: Emerging Technologies4Free
Chapter- 7: Evaluation of the Market Based on Geographic Region10Free
Chapter- 8: Patents16Free
Chapter- 9: Company Profiles39Free
Published - Sep-2020| Analyst - John Bergin| Code - BIO081C

Report Highlights

The global market for next generation cancer diagnostics is expected to grow from $6.2 billion in 2020 to $16.7 billion by 2025 with a compound annual growth rate (CAGR) of 21.9% for the period of 2020-2025.

Published - Aug-2014| Analyst - John Bergin| Code - BIO081B

Report Highlights

BCC Research estimates the global market for next generation cancer diagnostic as $1.6 billion in 2013. This indication is expected to reach $1.8 billion in 2014 and $10 billion in 2019, registering a compound annual growth (CAGR) of 42.6% over the next five years.

Published - Apr-2011| Analyst - John Bergin| Code - BIO081A

Report Highlights

The total global annual market for next generation cancer diagnostics was $776 million in 2010, and is growing at a compound annual growth rate (CAGR) of 47%, to reach a forecast market size of $5.3 billion in 2015.

Related Reports

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO150E

The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.

Global DNA Sequencing: Research, Applied and Clinical Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - BIO045J

The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.

Rare Disease Diagnostics: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM227B

The global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.

Direct-to-Consumer Genetic Testing: Global Markets and Technologies

Published - Nov 2024 | Publisher - Gundreddy Gopinadh | Code - MDS008B

The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.

Recent Reports

Cell-Based Assays: Technologies and Global Markets

Published - Feb 2025 | Publisher - BCC Publishing | Code - BIO080F

The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO150E

The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.

High Content Screening/Imaging: Technologies and Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO166C

The global market for high content screening and imaging (HCS/I) is estimated to increase from $3.4 billion in 2024 to reach $5.1 billion by 2029, at a compound annual growth rate (CAGR) of 8.4% from 2024 through 2029.

Biomarkers: Technologies and Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO061G

The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.

Bioprocess Optimization and Digital Bio-manufacturing: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - BIO170B

The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.

Top Trending Reports

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM062E

The global market for Alzheimer’s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.

Biomarkers: Technologies and Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO061G

The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.

In Vitro Diagnostics: Technologies and Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - HLC186D

The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

OTC Drugs, Medical Devices and Diagnostics: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - HLC251B

The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO150E

The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Next-Generation Cancer Diagnostics: Technologies and Global Markets
Sample Report